|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0101 USD | +26.25% |
|
+1.00% | -54.09% |
| Feb. 22 | Baudax Bio, Inc. Filed for Bankruptcy | CI |
| 2023 | Baudax Bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 | CI |
Baudax Bio, Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was USD 1.27 million compared to USD 1.08 million a year ago. Net loss was USD 58.8 million compared to USD 19.77 million a year ago.
Basic loss per share from continuing operations was USD 177.3 compared to USD 361.16 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -54.09% | 530K | |
| +41.79% | 54.04B | |
| +46.17% | 41.96B | |
| -0.56% | 41.92B | |
| -7.20% | 28.35B | |
| +12.59% | 26.35B | |
| -21.51% | 19B | |
| +6.92% | 13B | |
| +29.60% | 12.28B | |
| +24.91% | 12.19B |
BAUDAX BIO, INC. 
